VYNE THERAPEUTICS INC
VYNENASDAQ🏆 #3580 by market capUS Equity
$791.29▲ $52.62 (+6.65%)
Simulated price1h—
24h▲ 6.7%
7d▲ 3047.5%
14d▲ 3047.5%
30d▲ 2311.0%
1y▲ 4579.4%
🏦Market Cap
$21M
Small Cap
📈Revenue Growth (YoY)
-25.0%
Declining
📊Gross Margin
81.0%
High
💵FCF Margin
—
⚖️P/S Ratio
48.4x
Expensive
Otter Score
63
Fair
Trading Snapshot
- Day Range
- $787.29 – $794.56
- 52-Week Range
- $0.28 – $1.60
- Volume
- $2.63B
- Avg Volume
- $3.29B
- Shares Outstanding
- 33.4M
- Next Earnings
- Sep 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $436,223
- Last Q Revenue
- $99,563
- P/E Ratio
- —
- P/S Ratio
- 48.4x
- EPS (TTM)
- $-0.50
- Dividend Yield
- —
Why Investors Own VYNE
- ✓High-growth profile — revenue up +23.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 66% gross margin and 5% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$436,223▲ +22.4% YoY
Gross Margin (TTM)
65.9%▲ +4.5% YoY
Operating Income (TTM)
$64,997▲ +22.4% YoY
Free Cash Flow (TTM)
$23,556▲ +22.4% YoY
About VYNE THERAPEUTICS INC
A company profile for VYNE THERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
63/100
Analyst Price Target
ⓘAverage Target
$961.26
▲ +21.5% Upside
High Target$1,148.22
Low Target$832.27
Based on 29 analysts
Latest News & Updates
🚀
Reuters·2h ago
VYNE THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift VYNE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Bloomberg·1d ago
VYNE THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.